報

告

內

容

簡

介

報告內容簡介：

Healthcare is undergoing transformative shifts with the integration of innovations like gene editing, medical artificial intelligence (AI), and brain-machine interfaces. These advancements promise to enhance patient care, revolutionize diagnostics, and propel medical research forward. However, the pace of these developments introduces complex ethical, legal, and societal challenges.

This lecture will explore the ethical dimensions of emerging healthcare technologies, focusing on critical issues such as patient autonomy, informed consent, data privacy, and equitable access. Particular attention will be given to the ethical implications of gene editing, AI in diagnostics, and precision medicine, as well as the growing role of telehealth and remote care platforms. Issues such as algorithmic bias in AI, data security, and the need for equitable access to advanced medical tools will be discussed. By engaging in open dialogue and thoughtful regulation, we can ensure that technological progress contributes to a fair, inclusive, and ethically sound healthcare future.

報告人簡介：

Dr. Phang Kean Chang, the lead of the Unit of Medical Research Ethics at Universiti Malaya Medical Centre, is appointed as a Chartered Scientist of the UK Royal College of Biology and serves as a doctoral supervisor at the Department of Pathology, Faculty of Medicine, Universiti Malaya. With advanced qualifications, including three master’s degrees in Pathology, Public Health, and Health Research Ethics, along with a PhD in Pathology, Dr. Phang also contributes as a faculty member for the Master of Health Research Ethics (MOHRE) program at Universiti Malaya, collaborating with the Berman Institute of Bioethics, Johns Hopkins University, to promote health research ethics education. As a Senior Research Fellow with the Global Health Bioethics Network (GHBN) led by the University of Oxford, broader research interests of Dr. Phang span research ethics, public health ethics, and the ethics of emerging technologies.